| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |